NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension

Aim: The present study investigates the role of NF-κB in Bmpr2-related pulmonary hypertension (PH) using a murine model of PH with inducible overexpression of a cytoplasmic tail Bmpr2 mutation. Methods and Results: Electrophoretic mobility shift assay for nuclear extracts in Bmpr2R899X mouse lung an...

Full description

Bibliographic Details
Main Authors: Megha Talati, Haitham Mutlak, Kirk B. Lane, Wei Han, Anna Hemnes, Outi Mutlak, Tom Blackwell, Rinat Zaynagetdinov, Timothy S. Blackwell, James West
Format: Article
Language:English
Published: MDPI AG 2014-05-01
Series:Diseases
Subjects:
Online Access:http://www.mdpi.com/2079-9721/2/2/148
_version_ 1818271203771547648
author Megha Talati
Haitham Mutlak
Kirk B. Lane
Wei Han
Anna Hemnes
Outi Mutlak
Tom Blackwell
Rinat Zaynagetdinov
Timothy S. Blackwell
James West
author_facet Megha Talati
Haitham Mutlak
Kirk B. Lane
Wei Han
Anna Hemnes
Outi Mutlak
Tom Blackwell
Rinat Zaynagetdinov
Timothy S. Blackwell
James West
author_sort Megha Talati
collection DOAJ
description Aim: The present study investigates the role of NF-κB in Bmpr2-related pulmonary hypertension (PH) using a murine model of PH with inducible overexpression of a cytoplasmic tail Bmpr2 mutation. Methods and Results: Electrophoretic mobility shift assay for nuclear extracts in Bmpr2R899X mouse lung and immunohistochemistry for NF-κB p65 in human PAH lung demonstrate that NF-κB is activated in end-stage disease. Acute inflammation or expression of a constitutively active NF-κB elicits a strong suppression of the BMP pathway in mice inversely correlating to activation of NF-κB targets. However, Bmpr2 mutation does not result in NF-κB activation in early disease development as assessed by luciferase reporter mice. Moreover, Bmpr2 mutant mice in which NF-κB activation is genetically blocked develop PH indistinguishable from that without the block. Finally, delivery of a virus causing NF-κB activation strongly exacerbates development of PH in Bmpr2 mutant mice, associated with increased remodeling. Conclusion: NF-κB activation exacerbates, but is not required for Bmpr2-related PH. Pulmonary vascular-specific activation of NF-κB may be a “second hit” that drives penetrance in heritable PH.
first_indexed 2024-12-12T21:22:27Z
format Article
id doaj.art-df81727870de4bbc8cebe6c5402aeeca
institution Directory Open Access Journal
issn 2079-9721
language English
last_indexed 2024-12-12T21:22:27Z
publishDate 2014-05-01
publisher MDPI AG
record_format Article
series Diseases
spelling doaj.art-df81727870de4bbc8cebe6c5402aeeca2022-12-22T00:11:32ZengMDPI AGDiseases2079-97212014-05-012214816710.3390/diseases2020148diseases2020148NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary HypertensionMegha Talati0Haitham Mutlak1Kirk B. Lane2Wei Han3Anna Hemnes4Outi Mutlak5Tom Blackwell6Rinat Zaynagetdinov7Timothy S. Blackwell8James West9Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USADepartment of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Johann Wolfgang Goethe, Frankfurt 60590, GermanyDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USADivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USADivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USADepartment of Anesthesiology, University of Colorado Health Sciences Center, Denver, CO 80045, USADivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USADivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USADivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USADivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USAAim: The present study investigates the role of NF-κB in Bmpr2-related pulmonary hypertension (PH) using a murine model of PH with inducible overexpression of a cytoplasmic tail Bmpr2 mutation. Methods and Results: Electrophoretic mobility shift assay for nuclear extracts in Bmpr2R899X mouse lung and immunohistochemistry for NF-κB p65 in human PAH lung demonstrate that NF-κB is activated in end-stage disease. Acute inflammation or expression of a constitutively active NF-κB elicits a strong suppression of the BMP pathway in mice inversely correlating to activation of NF-κB targets. However, Bmpr2 mutation does not result in NF-κB activation in early disease development as assessed by luciferase reporter mice. Moreover, Bmpr2 mutant mice in which NF-κB activation is genetically blocked develop PH indistinguishable from that without the block. Finally, delivery of a virus causing NF-κB activation strongly exacerbates development of PH in Bmpr2 mutant mice, associated with increased remodeling. Conclusion: NF-κB activation exacerbates, but is not required for Bmpr2-related PH. Pulmonary vascular-specific activation of NF-κB may be a “second hit” that drives penetrance in heritable PH.http://www.mdpi.com/2079-9721/2/2/148pulmonary arterial hypertensionbone morphogenic protein receptor type 2NF-κBinflammation
spellingShingle Megha Talati
Haitham Mutlak
Kirk B. Lane
Wei Han
Anna Hemnes
Outi Mutlak
Tom Blackwell
Rinat Zaynagetdinov
Timothy S. Blackwell
James West
NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
Diseases
pulmonary arterial hypertension
bone morphogenic protein receptor type 2
NF-κB
inflammation
title NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
title_full NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
title_fullStr NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
title_full_unstemmed NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
title_short NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
title_sort nf κb activation exacerbates but is not required for murine bmpr2 related pulmonary hypertension
topic pulmonary arterial hypertension
bone morphogenic protein receptor type 2
NF-κB
inflammation
url http://www.mdpi.com/2079-9721/2/2/148
work_keys_str_mv AT meghatalati nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT haithammutlak nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT kirkblane nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT weihan nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT annahemnes nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT outimutlak nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT tomblackwell nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT rinatzaynagetdinov nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT timothysblackwell nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension
AT jameswest nfkbactivationexacerbatesbutisnotrequiredformurinebmpr2relatedpulmonaryhypertension